XML 25 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements Of Changes In Shareholders' Equity - USD ($)
$ in Millions
Total
Additional Paid-In Capital [Member]
Retained Earnings [Member]
AOCI, Equity Method Investment, Parent
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Total shareholders’ equity   $ 1.5 [1] $ 901.3 $ (50.6)
Common shares outstanding, beginning of period at Feb. 25, 2022 112,109,294      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock issuances 109,090      
Common stock repurchases (352,700)      
Performance and restricted stock units issued as common stock 1,123,037      
Common shares outstanding, end of period at Feb. 24, 2023 112,988,721      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock issuances [1]   1.0    
Common stock repurchases [1]   (3.9)    
Other comprehensive income (loss) $ (21.9)      
Accumulated Other Comprehensive Income (Loss), end of period at Feb. 24, 2023 (72.5)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 35.3      
Dividends paid     (57.3)  
Employee Benefits and Share-Based Compensation [1]   20.8    
Total shareholders’ equity $ 826.2 19.4 [1] 879.3 (72.5)
Common stock issuances 131,013      
Common stock repurchases (514,993)      
Performance and restricted stock units issued as common stock 1,622,631      
Common shares outstanding, end of period at Feb. 23, 2024 114,227,372      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock issuances [1] $ 1.1      
Common stock repurchases [1]   (4.2)    
Other comprehensive income (loss) 5.6      
Accumulated Other Comprehensive Income (Loss), end of period at Feb. 23, 2024 (66.9)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 81.1      
Dividends paid     (47.6)  
Employee Benefits and Share-Based Compensation [1]   24.9    
Total shareholders’ equity $ 887.1 41.2 [1] 912.8 (66.9)
Common stock issuances 76,477      
Common stock repurchases (2,872,396)      
Performance and restricted stock units issued as common stock 2,301,980      
Common shares outstanding, end of period at Feb. 28, 2025 113,733,433      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock issuances [1]   1.0    
Common stock repurchases [1]   (36.4)    
Other comprehensive income (loss) $ 3.4      
Accumulated Other Comprehensive Income (Loss), end of period at Feb. 28, 2025 (63.5)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 120.7      
Dividends paid     (47.6)  
Employee Benefits and Share-Based Compensation [1]   23.5    
Total shareholders’ equity $ 951.7 $ 29.3 [1] $ 985.9 $ (63.5)
[1] Shares of our Class A and Class B common stock have no par value; thus, there are no balances for common stock.